Stem price target lowered to $4 from $5.50 at Susquehanna

Susquehanna analyst Biju Perincheril lowered the firm’s price target on Stem to $4 from $5.50 and keeps a Positive rating on the shares. The firm said 4Q revenue missed guidance, causing EPS to fall below expectations. However, the company achieved positive adjusted EBITDA and non-GAAP gross margins were inline with their forecast.